A survival analysis of paediatric acute lymphoblastic leukaemia patients at the Moroccan University Hospital Centre of Rabat
Résumé
Introduction: Acute lymphoblastic leukaemia (ALL) is the most common childhood leukaemia and a significant cause of paediatric mortality worldwide.Morocco, as part of the World Health Organisation (WHO) Global Initiative for Childhood Cancer, aims to achieve a 60% survival rate for paediatric cancers by 2030.Objective: This study evaluates survival rates and prognostic factors for paediatric ALL patients treated according to the MARALL 2006 protocol at the University Hospital Centre Ibn Sina in Rabat, Morocco.Methods: A retrospective cohort study analysed data from 512 children diagnosed with ALL between June 2006 and December 2017.Sociodemographic, clinical and therapeutic data were collected.Kaplan-Meier and Cox regression analyses identified survival rates and prognostic factors.Results: Among the patients, 56.2% achieved complete remission after first-line treatment and 20.9% experienced relapse.The 1-, 3-and 5-year overall survival rates were 83%, 67% and 63%, respectively.Significant prognostic factors included age ≥10 years, white blood cell count >50,000/mm³ and elevated lactate dehydrogenase levels.Standard risk classification and B-cell immunophenotype were associated with better survival outcomes.Conclusion: This study highlights encouraging survival rates for paediatric ALL patients in Morocco, exceeding the WHO target of 60%.However, achieving the national goal of 80% survival requires further improvements in early diagnosis, treatment access and adoption of advanced therapies.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 29/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →